This science-backed method revolves around activating key arousal pathways with an FDA-approved peptide: PT-141 (bremelanotide), commonly known as the "Pink Shot." It addresses hypoactive sexual desire disorder (HSDD) by stimulating brain receptors involved in sexual motivation, leading to increased desire, better lubrication, heightened sensitivity, reduced pain during intercourse, and greater overall satisfactionwithout directly altering hormones.[1][2][3] Clinical trials show it can significantly improve sexual function scores in premenopausal women with HSDD, with up to 51% reporting enhanced desire compared to placebo groups, but its benefits extend to perimenopausal and postmenopausal women dealing with vaginal atrophy and low libido.[1] Weve long known that peptides can influence sexual health, but PT-141 stands out as the first FDA-approved injectable specifically for HSDD in women

11-12% estimated clinical trial average 3 Platform Features Expert Prescribing Evidence-backed protocols based on OMA* and AACE** guidelines and clinical research with guidance from ABOM-certified physicians.*** Fast, Flexible Access Visit as often as needed on-demand in as little as 30 minutes or by appointment
GLP-1 alternatives for weight loss GLP-1 agonists have surged in popularity over the last few years, but theyre not the only weight loss medications available
(Lausanne) 13 , 934775 (2022)